2018
DOI: 10.1080/15287394.2018.1460785
|View full text |Cite
|
Sign up to set email alerts
|

Protective effect ofPaeoniae radix albaroot extract on immune alterations in mice with atopic dermatitis

Abstract: Atopic dermatitis is a progressive inflammatory disease characterized by type 2 helper T cell (T2) reactivity. The aim of this study was to examine the therapeutic effects of Paeoniae radix alba root extract using a murine model of atopic dermatitis. Atopic dermatitis was induced in a murine model characterized by immune alterations skewed toward T2 reactivity and pathophysiological dermal alterations which resemble human atopic dermatitis. The root extract at 1% or 6% was applied to the mouse dorsal skin for … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 38 publications
1
13
0
Order By: Relevance
“…In this study, we found that SHCGT suppressed the increased Th2 and Th1 immune responses in mice with AD and that SCFAs also directly reduced the expression of IL-6 and ICAM-1 in TNF-α/INF-γ-induced keratinocytes. SHCGT contains several compounds that are known to attenuate AD, including berberine and paeoniflorin (Tsang et al, 2016;Jo et al, 2018), and was also found to decrease the expression of IL-6 in an in vitro model of AD in our study. However, the actual concentrations of these active compounds in SHCGT may be extremely low in the circulation after oral administration.…”
Section: Discussionsupporting
confidence: 74%
“…In this study, we found that SHCGT suppressed the increased Th2 and Th1 immune responses in mice with AD and that SCFAs also directly reduced the expression of IL-6 and ICAM-1 in TNF-α/INF-γ-induced keratinocytes. SHCGT contains several compounds that are known to attenuate AD, including berberine and paeoniflorin (Tsang et al, 2016;Jo et al, 2018), and was also found to decrease the expression of IL-6 in an in vitro model of AD in our study. However, the actual concentrations of these active compounds in SHCGT may be extremely low in the circulation after oral administration.…”
Section: Discussionsupporting
confidence: 74%
“…Extracts from natural sources contain multiple biological-active compounds and have gained increasing attention due to their diverse pharmacological actions [ 17 , 18 , 19 ]. For this reason, they have been developed as commercial products for improving human health [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
“…It is commonly used for blood deficiency, irregular menstruation, spontaneous sweating, night sweats, flank pain, abdominal pain, limb pain, headache, and dizziness. 6,7 Previous studies showed that PRA could be used for anti-inflammatory effects, 8 immune regulation, 9 treatment of depression 10,11 and anemia, 12 promotion of peripheral nerve regeneration, 13 and treatment of viral infections. 14 Modern studies of pharmacological mechanisms have found that the main active components of PRA include paeoniflorin, paeonol, paeonin, benzoylpaeoniflorin, albiflorin, oxypaeoniflorin, paeoniflorigenone, benzoic acid, β-sitosterol, and gal-lotannin.…”
Section: Pharmacological Studies On the Active Ingredients Of The Sixmentioning
confidence: 99%